Nasus Share Price
AMEX: NSRX | Healthcare$0.00
-$2.72 (--%) Nasus Stock Performance
Nasus Share Price Chart
$0.00$0.00
L
H
Nasus Annual Profit & Loss
All figures in USD
Nasus Balance Sheet
All figures in USD Million
Nasus Cash Flow
Annually
All figures in USD Million
About Nasus
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Nasus Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.23 | $2.63 | -18.07% |
Oct 2026 | $3.90 | $3.21 | -18.53% |
Sep 2026 | $3.87 | $3.94 | -2.72% |
Aug 2026 | $3.25 | $4.05 | +33.22% |
Jul 2026 | $3.52 | $3.04 | -14.61% |
Jun 2026 | $3.46 | $3.56 | +3.79% |
May 2026 | $2.64 | $3.43 | +20.14% |
Apr 2026 | $2.37 | $2.85 | +33.41% |
Mar 2026 | $4.00 | $2.14 | -60.66% |
Feb 2026 | $5.51 | $5.44 | -22.62% |
Jan 2026 | $8.00 | $7.03 | -20.56% |
Dec 2025 | $6.55 | $8.85 | +30.92% |